409 related articles for article (PubMed ID: 19106034)
21. Olanzapine effects on auditory sensory gating in schizophrenia.
Arango C; Summerfelt A; Buchanan RW
Am J Psychiatry; 2003 Nov; 160(11):2066-8. PubMed ID: 14594761
[TBL] [Abstract][Full Text] [Related]
22. Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia.
Becker J; Gomes I; Ghisolfi ES; Schuch A; Ramos FL; Ehlers JA; Nora DB; Lara DR; da Costa JC
Clin Neurophysiol; 2004 Feb; 115(2):396-401. PubMed ID: 14744582
[TBL] [Abstract][Full Text] [Related]
23. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects.
Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR
Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399
[TBL] [Abstract][Full Text] [Related]
24. MEG does not reveal impaired sensory gating in first-episode schizophrenia.
Bachmann S; Weisbrod M; Röhrig M; Schröder J; Thomas C; Scherg M; Rupp A
Schizophr Res; 2010 Aug; 121(1-3):131-8. PubMed ID: 20447805
[TBL] [Abstract][Full Text] [Related]
25. Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study.
Waldo MC; Woodward L; Adler LE
Psychiatry Res; 2010 Jan; 175(1-2):179-80. PubMed ID: 19959243
[TBL] [Abstract][Full Text] [Related]
26. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia.
Micoulaud-Franchi JA; Aramaki M; Geoffroy PA; Richieri R; Cermolacce M; Faget C; Ystad S; Kronland-Martinet R; Lancon C; Vion-Dury J
J Clin Psychopharmacol; 2015 Apr; 35(2):184-7. PubMed ID: 25587694
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychological correlates of P50 sensory gating in patients with schizophrenia.
Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MÁ; Soria C; Arango C
Schizophr Res; 2013 Jan; 143(1):102-6. PubMed ID: 23148896
[TBL] [Abstract][Full Text] [Related]
28. [Sensory gating of patients with first-episode schizophrenia].
Chen XS; Zhang MD; Wang HX; Lou CY; Wang JJ; Guo Q; Liu L; Gao CY; Liu P; Liu XW; Duan HJ; Guo FL; Liang JH; Chen C; Chen XW
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3457-9. PubMed ID: 16686059
[TBL] [Abstract][Full Text] [Related]
29. Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study.
Ji B; Mei W; Zhang JX; Jing J; Wu Q; Zhuo Y; Xiao Z
Exp Brain Res; 2013 Aug; 229(2):139-47. PubMed ID: 23820976
[TBL] [Abstract][Full Text] [Related]
30. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
[TBL] [Abstract][Full Text] [Related]
31. [Sensory gating P50 in schizophrenic patients with and without homicide].
Wang HX; Zhen WF; Ma X; Wang YP; Tian JH; Dou QS; Zhao HX
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2616-20. PubMed ID: 20137678
[TBL] [Abstract][Full Text] [Related]
32. Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.
Hazlett EA; Rothstein EG; Ferreira R; Silverman JM; Siever LJ; Olincy A
Schizophr Res; 2015 Feb; 161(2-3):283-90. PubMed ID: 25482574
[TBL] [Abstract][Full Text] [Related]
33. P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
Zhu XL; Tan SP; Wang ZR; Zhang JG; Li D; Fan FM; Zhao YL; Zou YZ; Tan YL; Yang F; Zhang XY
Neurosci Lett; 2017 Jul; 653():346-350. PubMed ID: 28606770
[TBL] [Abstract][Full Text] [Related]
34. Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.
Nagamoto HT; Adler LE; McRae KA; Huettl P; Cawthra E; Gerhardt G; Hea R; Griffith J
Neuropsychobiology; 1999; 39(1):10-7. PubMed ID: 9892854
[TBL] [Abstract][Full Text] [Related]
35. P50 sensory gating, cognitive deficits and depressive symptoms in first-episode antipsychotics-naïve schizophrenia.
Li S; Yu B; Wang D; Xia L; Wang L; Chen D; Xiu M; Zhang XY
J Affect Disord; 2023 Mar; 324():153-161. PubMed ID: 36587903
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of auditory P50 sensory gating in schizophrenia and bipolar disorder.
Atagun MI; Drukker M; Hall MH; Altun IK; Tatli SZ; Guloksuz S; van Os J; van Amelsvoort T
Psychiatry Res Neuroimaging; 2020 Jun; 300():111078. PubMed ID: 32361172
[TBL] [Abstract][Full Text] [Related]
37. P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate.
Myles-Worsley M
Am J Psychiatry; 2002 Dec; 159(12):2007-12. PubMed ID: 12450949
[TBL] [Abstract][Full Text] [Related]
38. Effects of stimuli intensity and frequency on auditory p50 and n100 sensory gating.
Moura GS; Triñanes-Pego Y; Carrillo-de-la-Peña MT
Adv Exp Med Biol; 2010; 657():5-17. PubMed ID: 20020339
[TBL] [Abstract][Full Text] [Related]
39. The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels.
Ucar E; Lehtinen EK; Glenthøj BY; Oranje B
J Psychopharmacol; 2012 Aug; 26(8):1113-8. PubMed ID: 22331175
[TBL] [Abstract][Full Text] [Related]
40. Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
Csomor PA; Preller KH; Geyer MA; Studerus E; Huber T; Vollenweider FX
Neuropsychopharmacology; 2014 Sep; 39(10):2485-96. PubMed ID: 24801767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
